CC
AHCO icon

Centiva Capital’s AdaptHealth AHCO Stock Holding History

Centiva Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,383
Closed -$330K – 1627
2024
Q3 		$330K Sell
29,383
-18,091
-38% -$192K 0.01% 1518
2024
Q2 		$475K Buy
47,474
+22,948
+94% +$233K 0.01% 1180
2024
Q1 		$282K Sell
24,526
-6,604
-21% -$56.1K 0.01% 1278
2023
Q4 		$227K Buy
+31,130
New +$245K 0.01% 1356
2023
Q3 		– Sell
-22,060
Closed -$268K – 1687
2023
Q2 		$268K Buy
+22,060
New +$246K 0.01% 1178
2022
Q4 		– Sell
-11,925
Closed -$224K – 1339
2022
Q3 		$224K Buy
+11,925
New +$245K ﹤0.01% 1144
2020
Q1 		– Sell
-16,513
Closed -$181K – 594
2019
Q4 		$181K Buy
+16,513
New +$164K 0.01% 696

Other funds holding AHCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Centiva Capital's AHCO Position: Q4 2024 in Review

Centiva Capital sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 29,383 shares — an estimated $330K sold.

Centiva Capital first reported a position in AHCO in Q4 2019 and held it in 7 quarters. The position peaked at $475K in Q2 2024. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

  • Centiva Capital reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 29,383 AdaptHealth shares in Q4 2024, an estimated $330K.
  • Centiva Capital first reported a position in AdaptHealth in Q4 2019 and held it in 7 quarters.
  • Centiva Capital's AdaptHealth position peaked at $475K in Q2 2024.
  • 200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.